×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [study drugs]
Presenter Disclosure Information Jochen Senges The following relationships exist related to this presentation: Speaker CompensationTrommsdorff ArzneimittelModest
215 views
DAIDS Safety Workshop: Part III Expedited Reporting via DAERS Albert Yoyin, M.D. and Archita Chatterjee, M.S. DAIDS RSC Safety Office Johannesburg, South
214 views
Phase-III Studie: HECTOR Topotecan plus Carboplatin (Paclitaxel plus Carboplatin oder Gemcitabin plus Carboplatin) -Intergroup Study of NOGGO und Studiengruppe
220 views
Presenter Disclosure Information Jochen Senges The following relationships exist related to this presentation: Speaker CompensationTrommsdorff ArzneimittelModest
213 views
Switch ABC/3TC to TDF/FTC SWIFT Study. SWIFT Study: Switch ABC/3TC to TDF/FTC Design Campo R, CID 2013, Jan 29 (epub ahead of print) LPV/rATV/rFPV
232 views
Adapted from the PMB through CTEP 2008 (revised 09/2014) NCORP-KC Guidelines for Investigational Drug Management
213 views
1 SWIFT Study: Switching From Lamivudine/Abacavir (3TC/ABC) to Emtricitabine/Tenofovir DF (FTC/TDF) R Campo 1, E DeJesus 2, H Khanlou 3, H Wang 4, K White
216 views
ClinicalTrials.gov Results Reporting from the Ground Up [Presenter Name and contact Info] 1
220 views
The Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca Heart Failure (GISSI-HF) trial GISSI-HF Adapted from: Tavazzi et al
224 views
The Good, The Bad and The Ugly of Clinical Research Sites
213 views
Cora Lee Wetherington, Ph.D. Women & Gender Research Coordinator National Institute on Drug Abuse Women Across the Life Span Conference July 12-13, 2004
215 views
Presentation Corex - ACTO, Moscow, 03 October 2012 Volkov Denis
226 views
Next >